Cutler Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2K | Sell |
500
-600
| -55% | -$2.78K | ﹤0.01% | 1878 |
|
|
2023
Q4 | $5K | Sell |
1,100
-703
| -39% | -$4.3K | ﹤0.01% | 2746 |
|
|
2023
Q3 | $13K | Buy |
1,803
+703
| +64% | +$5.62K | ﹤0.01% | 2328 |
|
|
2023
Q2 | $8K | Sell |
1,100
-200
| -15% | -$1.57K | ﹤0.01% | 2381 |
|
|
2023
Q1 | $9K | Buy |
+1,300
| New | +$12K | ﹤0.01% | 2384 |
|
|
2022
Q4 | – | Sell |
-3,780
| Closed | -$66.7K | – | 4948 |
|
|
2022
Q3 | $68K | Sell |
3,780
-25,463
| -87% | -$1.1M | ﹤0.01% | 1671 |
|
|
2022
Q2 | $1.5M | Buy |
29,243
+16,617
| +132% | +$861K | 0.1% | 235 |
|
|
2022
Q1 | $929K | Sell |
12,626
-10,432
| -45% | -$930K | 0.05% | 412 |
|
|
2021
Q4 | $3.3M | Buy |
23,058
+8,258
| +56% | +$1.42M | 0.14% | 151 |
|
|
2021
Q3 | $3.07M | Sell |
14,800
-400
| -3% | -$88.2K | 0.14% | 161 |
|
|
2021
Q2 | $3.23M | Buy |
15,200
+3,500
| +30% | +$641K | 0.15% | 144 |
|
|
2021
Q1 | $2.12M | Buy |
11,700
+640
| +6% | +$128K | 0.1% | 199 |
|
|
2020
Q4 | $1.23M | Sell |
11,060
-7,801
| -41% | -$829K | 0.06% | 340 |
|
|
2020
Q3 | $2.04M | Sell |
18,861
-4,339
| -19% | -$529K | 0.13% | 168 |
|
|
2020
Q2 | $1.93M | Buy |
23,200
+21,600
| +1,350% | +$826K | 0.13% | 168 |
|
|
2020
Q1 | $21K | Hold |
1,600
| – | – | ﹤0.01% | 2277 |
|
|
2019
Q4 | $6K | Sell |
1,600
-800
| -33% | -$3.47K | ﹤0.01% | 2951 |
|
|
2019
Q3 | $12K | Buy |
+2,400
| New | +$13.1K | ﹤0.01% | 2524 |
|
|
2019
Q2 | – | Sell |
-400
| Closed | -$3.15K | – | 4628 |
|
|
2019
Q1 | $4K | Buy |
+400
| New | +$12.6K | ﹤0.01% | 3059 |
|
|
2018
Q1 | – | Sell |
-119
| Closed | -$2K | – | 4987 |
|
|
2017
Q4 | $2K | Hold |
119
| – | – | ﹤0.01% | 4182 |
|
|
2017
Q3 | $2K | Sell |
119
-435
| -79% | -$9.74K | ﹤0.01% | 5130 |
|
|
2017
Q2 | $12K | Hold |
554
| – | – | ﹤0.01% | 3978 |
|
|
2017
Q1 | $14K | Sell |
554
-76
| -12% | -$2.09K | ﹤0.01% | 3723 |
|
|
2016
Q4 | $15K | Buy |
630
+399
| +173% | +$11.6K | ﹤0.01% | 3763 |
|
|
2016
Q3 | $9K | Sell |
231
-569
| -71% | -$73.5K | ﹤0.01% | 4333 |
|
|
2016
Q2 | $116K | Sell |
800
-375
| -32% | -$43K | 0.01% | 1559 |
|
|
2016
Q1 | $121K | Buy |
1,175
+360
| +44% | +$38.6K | 0.01% | 1438 |
|
|
2015
Q4 | $136K | Buy |
+815
| New | +$125K | 0.01% | 1500 |
|
Other funds holding NVAX
SCM
Cutler Group's NVAX Position: Q1 2024 in Review
Cutler Group reduced its Novavax (NVAX) stake by 55% in Q1 2024, selling an estimated $2.78K and leaving 500 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.
Cutler Group first reported a position in NVAX in Q4 2015 and has held it in 28 quarters since. The position peaked at $3.3M in Q4 2021. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.
- Cutler Group held 500 shares of Novavax worth $2K as of Q1 2024.
- Cutler Group sold 600 Novavax shares in Q1 2024, an estimated $2.78K.
- Novavax made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1878 holding.
- Cutler Group first reported a position in Novavax in Q4 2015 and has held it in 28 quarters since.
- Cutler Group's Novavax position peaked at $3.3M in Q4 2021.
- 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.